These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 708161)

  • 1. In vitro hepatic oxidative metabolism of antipyrine, phenytoin and phenylbutazone in rabbits with experimental renal failure.
    van Peer AP; Belpaire FM; Bogaert MG
    Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):346-7. PubMed ID: 708161
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro hepatic oxidative metabolism of antipyrine, phenytoin and phenylbutazone in uraemic rabbits.
    Van Peer AP; Belpaire FM; Bogaert MG
    J Pharm Pharmacol; 1980 Feb; 32(2):135-6. PubMed ID: 6103036
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of drugs in rabbits with experimental acute renal failure.
    Van Peer A; Belpaire F; Bogaert M
    Pharmacology; 1978; 17(6):307-14. PubMed ID: 733890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of antipyrine, phenylbutazone and phenytoin in experimental renal failure.
    Van Peer AP; Belpaire FM; Rosseel MT; Bogaert MG
    Pharmacology; 1981; 22(2):139-45. PubMed ID: 7208595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interindividual differences in rates of drug oxidation in man.
    Davies DS; Thorgeirsson SS; Breckenridge A; Orme M
    Drug Metab Dispos; 1973; 1(1):411-7. PubMed ID: 4149412
    [No Abstract]   [Full Text] [Related]  

  • 6. Binding of drugs in serum, blood cells and tissues of rabbits with experimental acute renal failure.
    Van Peer AP; Belpaire FM; Bogaert MG
    Pharmacology; 1981; 22(2):146-52. PubMed ID: 7208596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hydroxylation of drugs- a pharmacogenetic problem?
    Evans DA
    Proc R Soc Med; 1970 Feb; 63(2):178. PubMed ID: 4191705
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chronic renal failure as a factor modifying drug metabolism in the body].
    Orzechowska-Juzwenko K; Milejski P; Kazimierczak K; Szewczyk Z
    Pol Tyg Lek; 1986 Dec 22-29; 41(51-52):1638-40. PubMed ID: 3588383
    [No Abstract]   [Full Text] [Related]  

  • 9. Antipyrine kinetics in Nigerian women in chronic renal failure.
    Iyun AO; Tucker GT
    Afr J Med Med Sci; 1982 Mar; 11(1):7-9. PubMed ID: 6291357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of phenytoin and phenylbutazone in normal and uraemic rabbits.
    van Peer AP; Belpaire FM; Bogaert MG
    Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):348. PubMed ID: 708162
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic factors in hepatic drug oxidation.
    Kalow W; Inaba T
    Prog Liver Dis; 1976; 5():246-58. PubMed ID: 775542
    [No Abstract]   [Full Text] [Related]  

  • 12. [Oxidative hepatic metabolism in chronic alcoholics during the acute abstinence period: evaluation with antipyrine elimination].
    Soto Alvarez J; Alsar Ortiz MJ
    Rev Clin Esp; 1993 Jun; 193(2):60-3. PubMed ID: 8341815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetically dependent variability of drug effects].
    Goedee HW; Altland K
    Med Klin; 1970 Aug; 65(35):1507-17. PubMed ID: 4933855
    [No Abstract]   [Full Text] [Related]  

  • 14. Salivary antipyrine kinetics in hepatic and renal disease and in patients on anticonvulsant therapy.
    Harman AW; Penhall RK; Priestly BG; Frewin DB; Phillips PJ; Clarkson AR
    Aust N Z J Med; 1977 Aug; 7(4):385-90. PubMed ID: 270989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic oxidative drug metabolism in rats with experimental renal failure.
    Van Peer AP; Belpaire FM
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):180-3. PubMed ID: 921408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: extrapolation of data to benzodiazepines and phenytoin.
    Boxenbaum H
    J Pharmacokinet Biopharm; 1980 Apr; 8(2):165-76. PubMed ID: 6107379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative drug metabolism and inducibility by phenobarbital in sickle cell anemia.
    Anderson KE; Peterson CM; Alvares AP; Kappas A
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):580-7. PubMed ID: 913026
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of drug metabolism by hydroxylated metabolites: cross-inhibition and specificity.
    Soda DM; Levy G
    J Pharm Sci; 1975 Dec; 64(12):1928-31. PubMed ID: 1206483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of drug metabolism in the isolated perfused liver and in vivo in rats.
    von Bahr C; Alexanderson B; Azarnoff DL; Sjoqvist F; Orrenius S
    Eur J Pharmacol; 1970 Jan; 9(1):99-105. PubMed ID: 5434299
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug metabolism in uremia.
    Reidenberg MM
    Clin Nephrol; 1975; 4(3):83-5. PubMed ID: 1102176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.